DOI: 10.1016/s0924-8579(99)00115-6. The MYSTIC (meropenem yearly susceptibility test information collection) programme

The MYSTIC (meropenem yearly susceptibility test information collection) programme

10.1016/s0924-8579(99)00115-6

Crossref journal-article

Elsevier BV

International Journal of Antimicrobial Agents (78)

Authors 4

P.J Turner (first)
J.M Greenhalgh (additional)
J.R Edwards (additional)
J McKellar (additional)

References 40 Referenced 57

Luthy R, Neu HC, Phillips I. A perspective of imipenem. J Antimicrob Chemother 1983; 12; Suppl D. (10.1093/jac/12.suppl_D.iii)
Bint AJ, Speller DCE, Williams RJ. Imipenem-assessing its clinical role. J Antimicrob Chemother 1986; 18; Suppl E. (10.1093/jac/18.Supplement_E.iii)
Davey P, Davies A, Livermore D, Speller DCE, Daly PJ. Meropenem (SM7338) — a new carbapenem. J Antimicrob Chemother 1989; 24; Suppl A. (10.1093/jac/24.suppl_A.iii)
Finch RG, Bint AJ, White LO, Wood MJ, Daly PJ. Meropenem. focus on clinical performance. J Antimicrob Chemother 1995; 36; Suppl A. (10.1093/jac/36.suppl_A.iii)
10.1016/1069-417X(96)83893-3 / Antimicrobics. Inf. Dis. Newsletter. / Beta-lactamase-mediated resistance in gram-negative bacilli by Stratton (1996)
{'key': '10.1016/S0924-8579(99)00115-6_BIB6', 'first-page': '35', 'article-title': 'Incidence of multi-resistant gram-negative isolates in eight Dutch hospitals. The 1990 Dutch Surveillance Study', 'volume': '78', 'author': 'Buirma', 'year': '1991', 'journal-title': 'Scand. J. Infec. Dis. Suppl.'} / Scand. J. Infec. Dis. Suppl. / Incidence of multi-resistant gram-negative isolates in eight Dutch hospitals. The 1990 Dutch Surveillance Study by Buirma (1991)
{'key': '10.1016/S0924-8579(99)00115-6_BIB7', 'first-page': '45', 'article-title': 'Incidence of multi-resistance in Gram-negative bacterial isolates from intensive care units in Belgium: a surveillancve study', 'volume': '78', 'author': 'Verbist', 'year': '1991', 'journal-title': 'Scand. J. Infect. Dis. Suppl.'} / Scand. J. Infect. Dis. Suppl. / Incidence of multi-resistance in Gram-negative bacterial isolates from intensive care units in Belgium: a surveillancve study by Verbist (1991)
10.1093/jac/38.3.409 / J. Antimicrob. Chemother. / Antibiotic resistance and production of extended-spectrum beta-lactamase amongst Klebsiella spp. from intensive care units in Europe by Livermore (1996)
{'key': '10.1016/S0924-8579(99)00115-6_BIB9', 'first-page': '1', 'article-title': 'General mechanisms of resistance to antibiotics', 'volume': '22', 'author': 'Bryan', 'year': '1989', 'journal-title': 'J. Antimocrob. Chemother. (Suppl. A)'} / J. Antimocrob. Chemother. (Suppl. A) / General mechanisms of resistance to antibiotics by Bryan (1989)
10.1093/jac/29.3.349 / J. Antimicrob. Chemother. / The emergence of highly fluoroquinolone-resistant Escherichia coli in community-acquired urinary tract infections by Aguiar (1992)
{'key': '10.1016/S0924-8579(99)00115-6_BIB11', 'first-page': '474', 'article-title': 'Ciprofloxacin resistance in Gram-negative bacilli. Epidemiological aspects', 'volume': '11', 'author': 'Martinez-Martinez', 'year': '1993', 'journal-title': 'Enferm. Infec. Microbiol. Clin.'} / Enferm. Infec. Microbiol. Clin. / Ciprofloxacin resistance in Gram-negative bacilli. Epidemiological aspects by Martinez-Martinez (1993)
10.1128/AAC.41.3.563 / Antimicrob. Agents. Chemother. / Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid mediated AmpC β-lactamase, and the loss of an outer membrane protein by Bradford (1997)
10.1016/S0140-6736(05)62567-6 / Lancet / Emergence of a carbapenem-resistant Klebsiella pneumoniae by MacKenzie (1997)
10.1016/S0140-6736(05)75604-X / Lancet / Carbapenem-hydrolysing IMP-1 β-lactamase in Klebsiella pneumoniae from Singapore by Koh (1999)
10.1016/S0140-6736(98)05954-6 / Lancet / Appearance of IMP-1 metallo-β-lacatamase in Europe by Cornaglia (1999)
National Committee for Clinical Laboratory Standards, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically-Fourth edition; Approved Standard 1997; 17 (no 2), Wayne PA 19087 USA.
National Committee for Clinical Laboratory Standards, Methods for antimicrobial susceptibility testing of anaerobic bacteria; Approved Standard-Fourth edition 1997; 17 (no 22), Wayne PA 19087 USA.
10.1093/jac/36.suppl_A.1 / J. Antimicrob. Chemother; (Suppl. A) / Meropenem: a microbiological overview by Edwards (1995)
10.1093/jac/24.suppl_A.9 / J. Antimicrob. Chemother; (Suppl. A) / In-vitro studies of meropenem by Jones (1989)
10.1093/jac/12.suppl_D.37 / J. Antimicrob. Chemother; (Suppl. D) / Activity of imipenem on aerobic bacteria by Acar (1983)
Santos-Ferreira MO, Vital JO. In-vitro antibacterial activity of imipenem compared with four other beta-lactam antibiotics (ceftazidime, cefotaxime, piperacillin and azlocillin) against 828 separate clinical isolates from a Portuguese hospital. J Antimicrob Chemother 1986; (Suppl E):23–26. (10.1093/jac/18.Supplement_E.23)
10.1093/jac/38.3.523 / J. Antimicrob. Chemother. / Faulkener KL and the Meropenem Serious Infection Study Group, Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalised patients by Colardyn (1996)
10.1007/BF01700407 / Eur. J. Clin. Micro. Infec. Dis. / Prospective, randomised, multicentre study of meropenem versus imipenem/cilastatin as empiric monotherapy in severe nosocomial infections by Garau (1997)
10.1128/AAC.40.5.1108 / Antimicrob. Agents. Chemother. / Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer by Cometta (1996)
10.1093/jac/36.1.185 / J. Antimicrob. Chemother. / Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients by Boogaerts (1995)
Byrne S, Maddison J, Connor P, et al., Clinical evaluation of meropenem versus ceftazidime for the treatment of Pseudomonas spp. infections in cystic fibrosis patients. J Antimicrob Chemother 1995; 36 (Suppl A): 135–144. (10.1093/jac/36.suppl_A.135)
10.1097/00006454-199608000-00035 / Paediatr. Infect. Dis. J. / Use of carbapenems and other antibiotics for pulmonary infection in patients with cystic fibrosis by Hoieby (1996)
{'key': '10.1016/S0924-8579(99)00115-6_BIB28', 'first-page': '403', 'article-title': 'Meropenem versus tobramycin with clindamycin in the antibiotic management of patients with advanced appendicitis', 'volume': '182', 'author': 'Berne', 'year': '1996', 'journal-title': 'J. Amer. Coll. Surg.'} / J. Amer. Coll. Surg. / Meropenem versus tobramycin with clindamycin in the antibiotic management of patients with advanced appendicitis by Berne (1996)
10.1093/jac/36.suppl_A.191 / J. Antimicrob. Chemother; (Suppl. A) / Meropenem versus imipenem/cilastatin in intra-abdominal infections requiring surgery by Geroulanos (1995)
Hamacher J, Vogel F, Lichey J et al, Treatment of acute bacterial exacerbations of chronic obstructive pulmonary disease in hospitalised patients — a comparison of meropenem and imipenem/cilastatin. COPD Study Group. J Antimicrob Chemother 1995; 36 (Suppl A): 121–133. (10.1093/jac/36.suppl_A.121)
10.1097/00003246-199710000-00015 / Crit. Care. Med. / Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study by Sieger (1997)
{'issue': 'Suppl 4', 'key': '10.1016/S0924-8579(99)00115-6_BIB32', 'first-page': '11', 'article-title': 'Outer membrane proteins and susceptibility to carbapenems', 'volume': '5', 'author': 'Garcia de Lomas', 'year': '1992', 'journal-title': 'Span. J. Chemother.'} / Span. J. Chemother. / Outer membrane proteins and susceptibility to carbapenems by Garcia de Lomas (1992)
10.1007/BF01645538 / Infection / In-vitro activity and stability against novel beta-lactamases of investigational beta-lactams (cefepime, cefpirome, flomoxef, SCE 2787 and piperacillin plus tazobactam) in comparison with established compounds (cefotaxime, latamoxef and piperacillin) by Bauernfeind (1991)
10.1093/jac/25.2.199 / J. Antimicrob. Chemother. / Interactions of tazobactam and clavulanate with inducibly- and constitutively-expressed Class I beta-lactamases by Akova (1990)
10.1007/BF01982191 / Eur. J. Clin. Micro. Inf. Dis. / Bacteremia due to fluoroquinolone-resistant Escherichia coli in two immunocompromised patients by Kern (1994)
Cometta A, Calandra T, Bille J, Glauser MP, Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia. New Eng. J. Med. 1994; 330: 1240–1241. (10.1056/NEJM199404283301717)
10.1128/AAC.38.4.681 / Antimicro. Agents. Chemother. / Emergence of flouroquinolone-resistant Escherichia coli at a cancer centre by Kern (1994)
10.1128/AAC.39.2.520 / Antimicro. Agents. Chemother. / Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections by Pena (1995)
{'issue': 'Suppl 4', 'key': '10.1016/S0924-8579(99)00115-6_BIB39', 'first-page': '32', 'article-title': 'A compilation of studies assessing the in vitro activity of meropenem and comparators in 84 laboratories throughout Europe', 'volume': '3', 'author': 'Turner', 'year': '1997', 'journal-title': 'Clin. Micro. Inf.'} / Clin. Micro. Inf. / A compilation of studies assessing the in vitro activity of meropenem and comparators in 84 laboratories throughout Europe by Turner (1997)
Ciofu O, Jensen T, Pressler T, Johansen HK, Koch C, Hoeiby N, Meropenem in cystic fibrosis patients infected with resistant Pseudomonas aeruginosa or Burkholderia cepacia and with hypersensitivity to beta-lactam antibiotics. Clinical Micro and Infect 1996; 2 (2): 91–98. (10.1111/j.1469-0691.1996.tb00212.x)

Dates

Type	When
Created	23 years, 1 month ago (July 25, 2002, 11:17 a.m.)
Deposited	5 years, 7 months ago (Jan. 10, 2020, 1:18 a.m.)
Indexed	2 years, 6 months ago (March 2, 2023, 8:06 a.m.)
Issued	25 years, 11 months ago (Oct. 1, 1999)
Published	25 years, 11 months ago (Oct. 1, 1999)
Published Print	25 years, 11 months ago (Oct. 1, 1999)

Funders 0

None

BibTeX

@article{Turner_1999, title={The MYSTIC (meropenem yearly susceptibility test information collection) programme}, volume={13}, ISSN={0924-8579}, url={http://dx.doi.org/10.1016/s0924-8579(99)00115-6}, DOI={10.1016/s0924-8579(99)00115-6}, number={2}, journal={International Journal of Antimicrobial Agents}, publisher={Elsevier BV}, author={Turner, P.J and Greenhalgh, J.M and Edwards, J.R and McKellar, J}, year={1999}, month=oct, pages={117–125} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2023,
        3,
        2
      ]
    ],
    "date-time": "2023-03-02T13:06:49Z",
    "timestamp": 1677762409839
  },
  "reference-count": 40,
  "publisher": "Elsevier BV",
  "issue": "2",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            1999,
            10,
            1
          ]
        ],
        "date-time": "1999-10-01T00:00:00Z",
        "timestamp": 938736000000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        1999,
        10
      ]
    ]
  },
  "DOI": "10.1016/s0924-8579(99)00115-6",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2002,
        7,
        25
      ]
    ],
    "date-time": "2002-07-25T15:17:27Z",
    "timestamp": 1027610247000
  },
  "page": "117-125",
  "source": "Crossref",
  "is-referenced-by-count": 57,
  "title": "The MYSTIC (meropenem yearly susceptibility test information collection) programme",
  "prefix": "10.1016",
  "volume": "13",
  "author": [
    {
      "given": "P.J",
      "family": "Turner",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "J.M",
      "family": "Greenhalgh",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "J.R",
      "family": "Edwards",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "J",
      "family": "McKellar",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB1",
      "doi-asserted-by": "crossref",
      "unstructured": "Luthy R, Neu HC, Phillips I. A perspective of imipenem. J Antimicrob Chemother 1983; 12; Suppl D.",
      "DOI": "10.1093/jac/12.suppl_D.iii"
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB2",
      "doi-asserted-by": "crossref",
      "unstructured": "Bint AJ, Speller DCE, Williams RJ. Imipenem-assessing its clinical role. J Antimicrob Chemother 1986; 18; Suppl E.",
      "DOI": "10.1093/jac/18.Supplement_E.iii"
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB3",
      "doi-asserted-by": "crossref",
      "unstructured": "Davey P, Davies A, Livermore D, Speller DCE, Daly PJ. Meropenem (SM7338) \u2014 a new carbapenem. J Antimicrob Chemother 1989; 24; Suppl A.",
      "DOI": "10.1093/jac/24.suppl_A.iii"
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB4",
      "doi-asserted-by": "crossref",
      "unstructured": "Finch RG, Bint AJ, White LO, Wood MJ, Daly PJ. Meropenem. focus on clinical performance. J Antimicrob Chemother 1995; 36; Suppl A.",
      "DOI": "10.1093/jac/36.suppl_A.iii"
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB5",
      "doi-asserted-by": "crossref",
      "first-page": "29",
      "DOI": "10.1016/1069-417X(96)83893-3",
      "article-title": "Beta-lactamase-mediated resistance in gram-negative bacilli",
      "volume": "15",
      "author": "Stratton",
      "year": "1996",
      "journal-title": "Antimicrobics. Inf. Dis. Newsletter."
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB6",
      "first-page": "35",
      "article-title": "Incidence of multi-resistant gram-negative isolates in eight Dutch hospitals. The 1990 Dutch Surveillance Study",
      "volume": "78",
      "author": "Buirma",
      "year": "1991",
      "journal-title": "Scand. J. Infec. Dis. Suppl."
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB7",
      "first-page": "45",
      "article-title": "Incidence of multi-resistance in Gram-negative bacterial isolates from intensive care units in Belgium: a surveillancve study",
      "volume": "78",
      "author": "Verbist",
      "year": "1991",
      "journal-title": "Scand. J. Infect. Dis. Suppl."
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB8",
      "doi-asserted-by": "crossref",
      "first-page": "409",
      "DOI": "10.1093/jac/38.3.409",
      "article-title": "Antibiotic resistance and production of extended-spectrum beta-lactamase amongst Klebsiella spp. from intensive care units in Europe",
      "volume": "38",
      "author": "Livermore",
      "year": "1996",
      "journal-title": "J. Antimicrob. Chemother."
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB9",
      "first-page": "1",
      "article-title": "General mechanisms of resistance to antibiotics",
      "volume": "22",
      "author": "Bryan",
      "year": "1989",
      "journal-title": "J. Antimocrob. Chemother. (Suppl. A)"
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB10",
      "doi-asserted-by": "crossref",
      "first-page": "349",
      "DOI": "10.1093/jac/29.3.349",
      "article-title": "The emergence of highly fluoroquinolone-resistant Escherichia coli in community-acquired urinary tract infections",
      "volume": "29",
      "author": "Aguiar",
      "year": "1992",
      "journal-title": "J. Antimicrob. Chemother."
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB11",
      "first-page": "474",
      "article-title": "Ciprofloxacin resistance in Gram-negative bacilli. Epidemiological aspects",
      "volume": "11",
      "author": "Martinez-Martinez",
      "year": "1993",
      "journal-title": "Enferm. Infec. Microbiol. Clin."
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB12",
      "doi-asserted-by": "crossref",
      "first-page": "563",
      "DOI": "10.1128/AAC.41.3.563",
      "article-title": "Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid mediated AmpC \u03b2-lactamase, and the loss of an outer membrane protein",
      "volume": "41",
      "author": "Bradford",
      "year": "1997",
      "journal-title": "Antimicrob. Agents. Chemother."
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB13",
      "doi-asserted-by": "crossref",
      "first-page": "789",
      "DOI": "10.1016/S0140-6736(05)62567-6",
      "article-title": "Emergence of a carbapenem-resistant Klebsiella pneumoniae",
      "volume": "350",
      "author": "MacKenzie",
      "year": "1997",
      "journal-title": "Lancet"
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB14",
      "doi-asserted-by": "crossref",
      "first-page": "819",
      "DOI": "10.1016/S0140-6736(05)75604-X",
      "article-title": "Carbapenem-hydrolysing IMP-1 \u03b2-lactamase in Klebsiella pneumoniae from Singapore",
      "volume": "353",
      "author": "Koh",
      "year": "1999",
      "journal-title": "Lancet"
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB15",
      "doi-asserted-by": "crossref",
      "first-page": "899",
      "DOI": "10.1016/S0140-6736(98)05954-6",
      "article-title": "Appearance of IMP-1 metallo-\u03b2-lacatamase in Europe",
      "volume": "353",
      "author": "Cornaglia",
      "year": "1999",
      "journal-title": "Lancet"
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB16",
      "unstructured": "National Committee for Clinical Laboratory Standards, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically-Fourth edition; Approved Standard 1997; 17 (no 2), Wayne PA 19087 USA."
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB17",
      "unstructured": "National Committee for Clinical Laboratory Standards, Methods for antimicrobial susceptibility testing of anaerobic bacteria; Approved Standard-Fourth edition 1997; 17 (no 22), Wayne PA 19087 USA."
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB18",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1093/jac/36.suppl_A.1",
      "article-title": "Meropenem: a microbiological overview",
      "volume": "36",
      "author": "Edwards",
      "year": "1995",
      "journal-title": "J. Antimicrob. Chemother; (Suppl. A)"
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB19",
      "doi-asserted-by": "crossref",
      "first-page": "9",
      "DOI": "10.1093/jac/24.suppl_A.9",
      "article-title": "In-vitro studies of meropenem",
      "volume": "24",
      "author": "Jones",
      "year": "1989",
      "journal-title": "J. Antimicrob. Chemother; (Suppl. A)"
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB20",
      "doi-asserted-by": "crossref",
      "first-page": "37",
      "DOI": "10.1093/jac/12.suppl_D.37",
      "article-title": "Activity of imipenem on aerobic bacteria",
      "volume": "12",
      "author": "Acar",
      "year": "1983",
      "journal-title": "J. Antimicrob. Chemother; (Suppl. D)"
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB21",
      "doi-asserted-by": "crossref",
      "unstructured": "Santos-Ferreira MO, Vital JO. In-vitro antibacterial activity of imipenem compared with four other beta-lactam antibiotics (ceftazidime, cefotaxime, piperacillin and azlocillin) against 828 separate clinical isolates from a Portuguese hospital. J Antimicrob Chemother 1986; (Suppl E):23\u201326.",
      "DOI": "10.1093/jac/18.Supplement_E.23"
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB22",
      "doi-asserted-by": "crossref",
      "first-page": "523",
      "DOI": "10.1093/jac/38.3.523",
      "article-title": "Faulkener KL and the Meropenem Serious Infection Study Group, Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalised patients",
      "volume": "38",
      "author": "Colardyn",
      "year": "1996",
      "journal-title": "J. Antimicrob. Chemother."
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB23",
      "doi-asserted-by": "crossref",
      "first-page": "789",
      "DOI": "10.1007/BF01700407",
      "article-title": "Prospective, randomised, multicentre study of meropenem versus imipenem/cilastatin as empiric monotherapy in severe nosocomial infections",
      "volume": "16",
      "author": "Garau",
      "year": "1997",
      "journal-title": "Eur. J. Clin. Micro. Infec. Dis."
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB24",
      "doi-asserted-by": "crossref",
      "first-page": "1108",
      "DOI": "10.1128/AAC.40.5.1108",
      "article-title": "Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer",
      "volume": "40",
      "author": "Cometta",
      "year": "1996",
      "journal-title": "Antimicrob. Agents. Chemother."
    },
    {
      "issue": "1",
      "key": "10.1016/S0924-8579(99)00115-6_BIB25",
      "doi-asserted-by": "crossref",
      "first-page": "185",
      "DOI": "10.1093/jac/36.1.185",
      "article-title": "Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients",
      "volume": "36",
      "author": "Boogaerts",
      "year": "1995",
      "journal-title": "J. Antimicrob. Chemother."
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB26",
      "doi-asserted-by": "crossref",
      "unstructured": "Byrne S, Maddison J, Connor P, et al., Clinical evaluation of meropenem versus ceftazidime for the treatment of Pseudomonas spp. infections in cystic fibrosis patients. J Antimicrob Chemother 1995; 36 (Suppl A): 135\u2013144.",
      "DOI": "10.1093/jac/36.suppl_A.135"
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB27",
      "doi-asserted-by": "crossref",
      "first-page": "738",
      "DOI": "10.1097/00006454-199608000-00035",
      "article-title": "Use of carbapenems and other antibiotics for pulmonary infection in patients with cystic fibrosis",
      "volume": "15",
      "author": "Hoieby",
      "year": "1996",
      "journal-title": "Paediatr. Infect. Dis. J."
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB28",
      "first-page": "403",
      "article-title": "Meropenem versus tobramycin with clindamycin in the antibiotic management of patients with advanced appendicitis",
      "volume": "182",
      "author": "Berne",
      "year": "1996",
      "journal-title": "J. Amer. Coll. Surg."
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB29",
      "doi-asserted-by": "crossref",
      "first-page": "191",
      "DOI": "10.1093/jac/36.suppl_A.191",
      "article-title": "Meropenem versus imipenem/cilastatin in intra-abdominal infections requiring surgery",
      "volume": "36",
      "author": "Geroulanos",
      "year": "1995",
      "journal-title": "J. Antimicrob. Chemother; (Suppl. A)"
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB30",
      "doi-asserted-by": "crossref",
      "unstructured": "Hamacher J, Vogel F, Lichey J et al, Treatment of acute bacterial exacerbations of chronic obstructive pulmonary disease in hospitalised patients \u2014 a comparison of meropenem and imipenem/cilastatin. COPD Study Group. J Antimicrob Chemother 1995; 36 (Suppl A): 121\u2013133.",
      "DOI": "10.1093/jac/36.suppl_A.121"
    },
    {
      "issue": "10",
      "key": "10.1016/S0924-8579(99)00115-6_BIB31",
      "doi-asserted-by": "crossref",
      "first-page": "1663",
      "DOI": "10.1097/00003246-199710000-00015",
      "article-title": "Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study",
      "volume": "25",
      "author": "Sieger",
      "year": "1997",
      "journal-title": "Crit. Care. Med."
    },
    {
      "issue": "Suppl 4",
      "key": "10.1016/S0924-8579(99)00115-6_BIB32",
      "first-page": "11",
      "article-title": "Outer membrane proteins and susceptibility to carbapenems",
      "volume": "5",
      "author": "Garcia de Lomas",
      "year": "1992",
      "journal-title": "Span. J. Chemother."
    },
    {
      "issue": "Suppl 5",
      "key": "10.1016/S0924-8579(99)00115-6_BIB33",
      "doi-asserted-by": "crossref",
      "first-page": "264",
      "DOI": "10.1007/BF01645538",
      "article-title": "In-vitro activity and stability against novel beta-lactamases of investigational beta-lactams (cefepime, cefpirome, flomoxef, SCE 2787 and piperacillin plus tazobactam) in comparison with established compounds (cefotaxime, latamoxef and piperacillin)",
      "volume": "19",
      "author": "Bauernfeind",
      "year": "1991",
      "journal-title": "Infection"
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB34",
      "doi-asserted-by": "crossref",
      "first-page": "199",
      "DOI": "10.1093/jac/25.2.199",
      "article-title": "Interactions of tazobactam and clavulanate with inducibly- and constitutively-expressed Class I beta-lactamases",
      "volume": "25",
      "author": "Akova",
      "year": "1990",
      "journal-title": "J. Antimicrob. Chemother."
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB35",
      "doi-asserted-by": "crossref",
      "first-page": "161",
      "DOI": "10.1007/BF01982191",
      "article-title": "Bacteremia due to fluoroquinolone-resistant Escherichia coli in two immunocompromised patients",
      "volume": "13",
      "author": "Kern",
      "year": "1994",
      "journal-title": "Eur. J. Clin. Micro. Inf. Dis."
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB36",
      "doi-asserted-by": "crossref",
      "unstructured": "Cometta A, Calandra T, Bille J, Glauser MP, Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia. New Eng. J. Med. 1994; 330: 1240\u20131241.",
      "DOI": "10.1056/NEJM199404283301717"
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB37",
      "doi-asserted-by": "crossref",
      "first-page": "681",
      "DOI": "10.1128/AAC.38.4.681",
      "article-title": "Emergence of flouroquinolone-resistant Escherichia coli at a cancer centre",
      "volume": "38",
      "author": "Kern",
      "year": "1994",
      "journal-title": "Antimicro. Agents. Chemother."
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB38",
      "doi-asserted-by": "crossref",
      "first-page": "520",
      "DOI": "10.1128/AAC.39.2.520",
      "article-title": "Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections",
      "volume": "39",
      "author": "Pena",
      "year": "1995",
      "journal-title": "Antimicro. Agents. Chemother."
    },
    {
      "issue": "Suppl 4",
      "key": "10.1016/S0924-8579(99)00115-6_BIB39",
      "first-page": "32",
      "article-title": "A compilation of studies assessing the in vitro activity of meropenem and comparators in 84 laboratories throughout Europe",
      "volume": "3",
      "author": "Turner",
      "year": "1997",
      "journal-title": "Clin. Micro. Inf."
    },
    {
      "key": "10.1016/S0924-8579(99)00115-6_BIB40",
      "doi-asserted-by": "crossref",
      "unstructured": "Ciofu O, Jensen T, Pressler T, Johansen HK, Koch C, Hoeiby N, Meropenem in cystic fibrosis patients infected with resistant Pseudomonas aeruginosa or Burkholderia cepacia and with hypersensitivity to beta-lactam antibiotics. Clinical Micro and Infect 1996; 2 (2): 91\u201398.",
      "DOI": "10.1111/j.1469-0691.1996.tb00212.x"
    }
  ],
  "container-title": "International Journal of Antimicrobial Agents",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0924857999001156?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0924857999001156?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2020,
        1,
        10
      ]
    ],
    "date-time": "2020-01-10T06:18:31Z",
    "timestamp": 1578637111000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0924857999001156"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        1999,
        10
      ]
    ]
  },
  "references-count": 40,
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          1999,
          10
        ]
      ]
    }
  },
  "alternative-id": [
    "S0924857999001156"
  ],
  "URL": "http://dx.doi.org/10.1016/S0924-8579(99)00115-6",
  "relation": {},
  "ISSN": [
    "0924-8579"
  ],
  "subject": [],
  "container-title-short": "International Journal of Antimicrobial Agents",
  "published": {
    "date-parts": [
      [
        1999,
        10
      ]
    ]
  }
}